Search tool

This 2001 document is the final report of a field trial conducted on DRD-Standard, version 1.0. The report describes the results of the field trial, which was conducted with the aim of...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

The 2001–03 work programme provides a new working framework for the EMCDDA. It is based on the EMCDDA founding regulation; the EU Joint action on new synthetic drugs, adopted on 16th June...

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA's activities over a 12-month period. Published every spring, it catalogues the Centre's achievements in each...

The 2001 Annual work programme defines the projects to be undertaken in the various thematic areas outlined in the 2001–03 work programme and is the first step towards implementing the goals and...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the National focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...